Phathom Pharmaceuticals Upcoming Investor Conferences
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT), a dedicated biopharmaceutical company, is making strides in the realm of gastrointestinal (GI) diseases. The company aims to develop groundbreaking treatments that can substantially improve the lives of patients suffering from such conditions. Today, we share exciting news about the company’s participation in several important investor conferences scheduled for the upcoming months.
Highlighted Conference Participation
The management team at Phathom Pharmaceuticals is gearing up to present at various conferences where they will engage with investors, showcasing their innovative solutions and discussing their vision for the future. Here’s a glimpse of their scheduled appearances:
Guggenheim's Inaugural Healthcare Innovation Conference
This premier event takes place in Boston. The conference will feature a live webcast event on the morning of November 12, where Phathom’s management is expected to participate in targeted one-on-one meetings. This platform provides them an opportunity to elaborate on their new initiatives and answer investor inquiries.
Stifel 2024 Healthcare Conference
Another important event is the Stifel Healthcare Conference in New York, set for November 18. Phathom’s management will engage with attendees during scheduled meetings to discuss their pioneering treatments and ongoing enhancements in their development programs.
Jefferies London Healthcare Conference
Moving across the ocean, the Jefferies London Healthcare Conference on November 20 will give Phathom an international platform to connect with global investors. The management team's participation underscores their commitment to broadening relationships with shareholders.
7th Annual Evercore HealthCONx Conference
This much-anticipated event in Coral Gables, happening on December 3, will again give the management team a chance to highlight their latest accomplishments and strategic goals in front of investment professionals.
Accessing Conference Information
Listening to these discussions and presentations is vital for investors who want to keep a finger on the pulse of Phathom Pharmaceuticals’ advancements. Interested individuals can access the live webcasts and obtain archived recordings on the Phathom Pharmaceuticals website. This makes it convenient for stakeholders to catch up with real-time insights and future plans.
About Phathom Pharmaceuticals
Phathom Pharmaceuticals is committed to redefining treatment landscapes within gastrointestinal health. Their flagship product, vonoprazan, represents a significant step forward in the treatment of various GI disorders, including Non-Erosive GERD and the eradication of H. pylori infection in adults. Marketed as VOQUEZNA, this innovative product is gaining momentum as an industry leader. The company aims to continue expanding its portfolio, focusing on drawing from innovative methods and strategic collaborations for future solutions.
Stay Connected with Phathom
For ongoing updates and further information, stakeholders are encouraged to visit Phathom's official website and follow them on LinkedIn and X to remain informed about their trajectory. Phathom is on a mission to ensure that effective treatments for GI diseases are accessible to those in need.
Frequently Asked Questions
What is Phathom Pharmaceuticals focused on?
Phathom Pharmaceuticals is focused on developing and commercializing innovative treatments for gastrointestinal diseases, particularly with their lead product, vonoprazan.
When is Phathom participating in conferences?
Phathom Pharmaceuticals will participate in several key conferences in November and December, including events in Boston, New York, London, and Coral Gables.
How can I access the webcasts of the conferences?
You can access live webcasts and recordings of the conferences through the News & Events section of the Phathom website.
What does vonoprazan treat?
Vonoprazan treats conditions like heartburn associated with Non-Erosive GERD and helps in the healing of Erosive GERD while also addressing H. pylori infections.
How can I stay updated with Phathom Pharmaceuticals?
For the latest updates, you can visit their official website and follow them on platforms like LinkedIn and X.
